Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Transcription and chromatin determinants of de novo DNA methylation timing in oocytes

L. Gahurova, SI. Tomizawa, SA. Smallwood, KR. Stewart-Morgan, H. Saadeh, J. Kim, SR. Andrews, T. Chen, G. Kelsey,

. 2017 ; 10 (-) : 25. [pub] 20170512

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17030808

BACKGROUND: Gametogenesis in mammals entails profound re-patterning of the epigenome. In the female germline, DNA methylation is acquired late in oogenesis from an essentially unmethylated baseline and is established largely as a consequence of transcription events. Molecular and functional studies have shown that imprinted genes become methylated at different times during oocyte growth; however, little is known about the kinetics of methylation gain genome wide and the reasons for asynchrony in methylation at imprinted loci. RESULTS: Given the predominant role of transcription, we sought to investigate whether transcription timing is rate limiting for de novo methylation and determines the asynchrony of methylation events. Therefore, we generated genome-wide methylation and transcriptome maps of size-selected, growing oocytes to capture the onset and progression of methylation. We find that most sequence elements, including most classes of transposable elements, acquire methylation at similar rates overall. However, methylation of CpG islands (CGIs) is delayed compared with the genome average and there are reproducible differences amongst CGIs in onset of methylation. Although more highly transcribed genes acquire methylation earlier, the major transitions in the oocyte transcriptome occur well before the de novo methylation phase, indicating that transcription is generally not rate limiting in conferring permissiveness to DNA methylation. Instead, CGI methylation timing negatively correlates with enrichment for histone 3 lysine 4 (H3K4) methylation and dependence on the H3K4 demethylases KDM1A and KDM1B, implicating chromatin remodelling as a major determinant of methylation timing. We also identified differential enrichment of transcription factor binding motifs in CGIs acquiring methylation early or late in oocyte growth. By combining these parameters into multiple regression models, we were able to account for about a fifth of the variation in methylation timing of CGIs. Finally, we show that establishment of non-CpG methylation, which is prevalent in fully grown oocytes, and methylation over non-transcribed regions, are later events in oogenesis. CONCLUSIONS: These results do not support a major role for transcriptional transitions in the time of onset of DNA methylation in the oocyte, but suggest a model in which sequences least dependent on chromatin remodelling are the earliest to become permissive for methylation.

000      
00000naa a2200000 a 4500
001      
bmc17030808
003      
CZ-PrNML
005      
20171102114729.0
007      
ta
008      
171025s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13072-017-0133-5 $2 doi
035    __
$a (PubMed)28507606
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gahurova, Lenka $u Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK. Laboratory of Developmental Biology and Genetics, Department of Molecular Biology, University of South Bohemia, 37005 Ceske Budejovice, Czech Republic.
245    10
$a Transcription and chromatin determinants of de novo DNA methylation timing in oocytes / $c L. Gahurova, SI. Tomizawa, SA. Smallwood, KR. Stewart-Morgan, H. Saadeh, J. Kim, SR. Andrews, T. Chen, G. Kelsey,
520    9_
$a BACKGROUND: Gametogenesis in mammals entails profound re-patterning of the epigenome. In the female germline, DNA methylation is acquired late in oogenesis from an essentially unmethylated baseline and is established largely as a consequence of transcription events. Molecular and functional studies have shown that imprinted genes become methylated at different times during oocyte growth; however, little is known about the kinetics of methylation gain genome wide and the reasons for asynchrony in methylation at imprinted loci. RESULTS: Given the predominant role of transcription, we sought to investigate whether transcription timing is rate limiting for de novo methylation and determines the asynchrony of methylation events. Therefore, we generated genome-wide methylation and transcriptome maps of size-selected, growing oocytes to capture the onset and progression of methylation. We find that most sequence elements, including most classes of transposable elements, acquire methylation at similar rates overall. However, methylation of CpG islands (CGIs) is delayed compared with the genome average and there are reproducible differences amongst CGIs in onset of methylation. Although more highly transcribed genes acquire methylation earlier, the major transitions in the oocyte transcriptome occur well before the de novo methylation phase, indicating that transcription is generally not rate limiting in conferring permissiveness to DNA methylation. Instead, CGI methylation timing negatively correlates with enrichment for histone 3 lysine 4 (H3K4) methylation and dependence on the H3K4 demethylases KDM1A and KDM1B, implicating chromatin remodelling as a major determinant of methylation timing. We also identified differential enrichment of transcription factor binding motifs in CGIs acquiring methylation early or late in oocyte growth. By combining these parameters into multiple regression models, we were able to account for about a fifth of the variation in methylation timing of CGIs. Finally, we show that establishment of non-CpG methylation, which is prevalent in fully grown oocytes, and methylation over non-transcribed regions, are later events in oogenesis. CONCLUSIONS: These results do not support a major role for transcriptional transitions in the time of onset of DNA methylation in the oocyte, but suggest a model in which sequences least dependent on chromatin remodelling are the earliest to become permissive for methylation.
650    _2
$a zvířata $7 D000818
650    _2
$a chromatin $x genetika $7 D002843
650    _2
$a restrukturace chromatinu $7 D042002
650    _2
$a CpG ostrůvky $x genetika $7 D018899
650    _2
$a DNA-(cytosin-5-)methyltransferasa $x genetika $7 D004248
650    _2
$a metylace DNA $x genetika $7 D019175
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genomový imprinting $x genetika $7 D018392
650    _2
$a zárodečné buňky $7 D005854
650    _2
$a histony $x genetika $7 D006657
650    _2
$a myši $7 D051379
650    _2
$a oocyty $x růst a vývoj $x metabolismus $7 D009865
650    _2
$a oogeneze $x genetika $7 D009866
650    12
$a genetická transkripce $7 D014158
650    _2
$a transkriptom $x genetika $7 D059467
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tomizawa, Shin-Ichi $u Department of Histology and Cell Biology, School of Medicine, Yokohama City University, Yokohama, 236-0004 Japan.
700    1_
$a Smallwood, Sébastien A $u Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK. Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
700    1_
$a Stewart-Morgan, Kathleen R $u Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK. Biotech Research and Innovation Centre (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.
700    1_
$a Saadeh, Heba $u Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK. Computer Science Department, KASIT, University of Jordan, Amman, Jordan.
700    1_
$a Kim, Jeesun $u Department of Epigenetics and Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 77030 USA.
700    1_
$a Andrews, Simon R $u Bioinformatics Group, Babraham Institute, Cambridge, CB22 3AT UK. $7 gn_A_00006614
700    1_
$a Chen, Taiping $u Department of Epigenetics and Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 77030 USA.
700    1_
$a Kelsey, Gavin $u Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK. Centre for Trophoblast Research, University of Cambridge, Cambridge, CB2 3EG UK.
773    0_
$w MED00174307 $t Epigenetics & chromatin $x 1756-8935 $g Roč. 10, č. - (2017), s. 25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28507606 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171102114822 $b ABA008
999    __
$a ok $b bmc $g 1254401 $s 991835
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 10 $c - $d 25 $e 20170512 $i 1756-8935 $m Epigenetics & chromatin $n Epigenetics Chromatin $x MED00174307
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...